Ekttitab Holding Co KSCC (DFM:EKTTITAB) Research & Development: د.إ0.00 Mil (TTM As of Mar. 2026)


DFM:EKTTITAB Ekttitab Holding Co KSCC DFM:EKTTITAB
19 GF Score
Price د.إ0.44
GF Value د.إ0.07
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Ekttitab Holding Co KSCC Research & Development?

Ekttitab Holding Co KSCC DFM:EKTTITAB +0.23% 19 Research & Development is د.إ0.00 Mil as of Mar. 2026. GuruFocus rates DFM:EKTTITAB with a GF Score™ of 19/100 and a GF Value™ of د.إ0.07 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ekttitab Holding Co KSCC's Research & Development for the three months ended in Mar. 2026 was د.إ0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was د.إ0.00 Mil.

Ekttitab Holding Co KSCC  (DFM:EKTTITAB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ekttitab Holding Co KSCC Research & Development Related Terms

Ekttitab Holding Co KSCC Research & Development Historical Data

* Premium members only.

The historical data trend for Ekttitab Holding Co KSCC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekttitab Holding Co KSCC Research & Development Chart

Ekttitab Holding Co KSCC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ekttitab Holding Co KSCC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DFM:EKTTITAB
19GF Score
Ekttitab Holding Co KSCC DFM:EKTTITAB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekttitab Holding Co KSCC Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of د.إ0.00 Mil mean?
Ekttitab Holding Co KSCC (DFM:EKTTITAB) has a Research & Development of د.إ0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ekttitab Holding Co KSCC and its competitors.
Is Ekttitab Holding Co KSCC's Research & Development too high?
Ekttitab Holding Co KSCC's current Research & Development is د.إ0.00 Mil. Overall, Ekttitab Holding Co KSCC has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekttitab Holding Co KSCC's Research & Development compare to BLK and BX?
Ekttitab Holding Co KSCC's Research & Development of د.إ0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ekttitab Holding Co KSCC and its competitors. Ekttitab Holding Co KSCC's current Research & Development is د.إ0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekttitab Holding Co KSCC stock overvalued right now?
Based on GuruFocus' analysis, Ekttitab Holding Co KSCC (DFM:EKTTITAB) is currently considered Significantly Overvalued. The stock's GF Value™ is د.إ0.07, compared to a current price of د.إ0.44 — trading 525.7% above its estimated fair value. The current Research & Development is د.إ0.00 Mil. Ekttitab Holding Co KSCC's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ekttitab Holding Co KSCC (DFM:EKTTITAB), the current Research & Development is د.إ0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekttitab Holding Co KSCC (DFM:EKTTITAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ekttitab Holding Co KSCC stock appears to be overvalued. The current stock price of د.إ0.44 is trading 525.7% above its estimated GF Value™ of د.إ0.07. GuruFocus considers Ekttitab Holding Co KSCC to be Significantly Overvalued.

Key valuation signals for DFM:EKTTITAB:

  • Research & Development: د.إ0.00 Mil
  • GF Value™: د.إ0.07 vs. price of د.إ0.44 (525.7% above fair value)
  • GF Score™: 19/100 with 1 warning sign

No single metric tells the full story. See the DFM:EKTTITAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ekttitab Holding Co KSCC Business Description

Other Exchanges EKTTITAB:Kuwait
Address Al-Sharq, Jaber Al Mubarak Street, P.O BOX 9972, Heirs of Yaqoub Yousef Behbehani & Partners Building, Floor (16) - Unit 14, Block (5) - Plot 4, Safat, KWT, 82031
Ekttitab Holding Co KSCC is engaged principally in incorporating and acquiring Kuwait and foreign companies, extending borrowings and acting as grantor for such companies. The company provides financing and guarantees to affiliated companies, and invests in their shares where it holds a minimum ownership stake. It also owns and licenses intellectual property rights, holds movable and immovable assets necessary for its operations, and invests surplus funds through managed investment portfolios. The company operates in one segment, investments, and the majority of the Group's assets and operations are located within the State of Kuwait.
19GF Score

Get the complete analysis for DFM:EKTTITAB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ0.44
Price
د.إ0.07
GF Value